Physician profile
Ryan P Terlecki
NPI 1225235021
$218,936.55
in general payments reported to CMS, 2019-2025
9 companies · $39K in 2025
The $39K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $15K · 2021: $6,532 · 2022: $33K · 2023: $33K · 2024: $36K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Consulting Fee: $37K · Travel and Lodging: $7,555 · Food and Beverage: $6,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,500.00 |
| Consulting Fee | $36,700.00 |
| Travel and Lodging | $7,554.77 |
| Food and Beverage | $6,123.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $216,276.87 | 2019-2025 | General - Erectile Dysfunction, Advance Xp, Tactra |
| Swan Valley Medical Incorporated | $1,082.49 | 2023 | |
| Procept Biorobotics Corporation | $1,015.90 | 2025 | |
| Valencia Technologies Corporation | $131.61 | 2025 | Ecoin Device Kit |
| Ambu INC. | $117.83 | 2023 | |
| Astellas Pharma US INC | $114.79 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $113.79 | 2023-2024 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $67.78 | 2022 | |
| Coloplast Corp | $15.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Terlecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.